Trial Profile
A Multi-center, Open, Randomized, Parallel-group, 2 Arm Study to Compare the Efficacy and Safety of Amaryl(Rm)M 1/500mg Twice Daily Versus Amaryl® 4mg Both in Combination With Lantus(Rm) Once-daily Regimen in Type 2 Diabetes Mellitus Patients With Inadequate Glycemic Control
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Glimepiride/metformin (Primary) ; Glimepiride; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Handok Inc
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 16 Sep 2011 Status changed from recruiting to completed.